261 related articles for article (PubMed ID: 22399508)
1. Biological relevance of medullary thyroid microcarcinoma.
Machens A; Dralle H
J Clin Endocrinol Metab; 2012 May; 97(5):1547-53. PubMed ID: 22399508
[TBL] [Abstract][Full Text] [Related]
2. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
3. Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutations.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2014 Feb; 99(2):E286-92. PubMed ID: 24297798
[TBL] [Abstract][Full Text] [Related]
4. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
Machens A; Dralle H
J Clin Endocrinol Metab; 2010 Jun; 95(6):2655-63. PubMed ID: 20339026
[TBL] [Abstract][Full Text] [Related]
5. Skip metastases in thyroid cancer leaping the central lymph node compartment.
Machens A; Holzhausen HJ; Dralle H
Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
[TBL] [Abstract][Full Text] [Related]
6. Disparities between male and female patients with thyroid cancers: sex difference or gender divide?
Machens A; Hauptmann S; Dralle H
Clin Endocrinol (Oxf); 2006 Oct; 65(4):500-5. PubMed ID: 16984243
[TBL] [Abstract][Full Text] [Related]
7. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
8. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination?
Machens A; Hauptmann S; Dralle H
J Clin Endocrinol Metab; 2008 Jun; 93(6):2234-8. PubMed ID: 18364379
[TBL] [Abstract][Full Text] [Related]
10. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
Machens A; Lorenz K; Dralle H
Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
[TBL] [Abstract][Full Text] [Related]
11. Occult sporadic medullary microcarcinoma with lymph node metastases.
Sironi M; Cozzi L; Pareschi R; Spreafico GL; Assi A
Diagn Cytopathol; 1999 Sep; 21(3):203-6. PubMed ID: 10450108
[TBL] [Abstract][Full Text] [Related]
12. Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.
Beressi N; Campos JM; Beressi JP; Franc B; Niccoli-Sire P; Conte-Devolx B; Murat A; Caron P; Baldet L; Kraimps JL; Cohen R; Bigorgne JC; Chabre O; Lecomte P; Modigliani E
Thyroid; 1998 Nov; 8(11):1039-44. PubMed ID: 9848720
[TBL] [Abstract][Full Text] [Related]
13. Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.
Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Haas OA; Vierhapper H; Niederle B
Am J Surg Pathol; 2001 Oct; 25(10):1245-51. PubMed ID: 11688458
[TBL] [Abstract][Full Text] [Related]
14. Mixed medullary-papillary carcinoma of the thyroid with lymph node metastases: report of a case.
Shiroko T; Yokoo N; Okamoto K; Kitakado Y; Azuma H; Fukui T; Tanaka C
Surg Today; 2001; 31(4):317-21. PubMed ID: 11321340
[TBL] [Abstract][Full Text] [Related]
15. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
16. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in medullary thyroid microcarcinomas.
Santrac N; Markovic I; Medic Milijic N; Goran M; Buta M; Djurisic I; Dzodic R
Endocr J; 2020 Mar; 67(3):295-304. PubMed ID: 31801918
[TBL] [Abstract][Full Text] [Related]
18. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
19. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis.
Machens A; Gimm O; Ukkat J; Hinze R; Schneyer U; Dralle H
Cancer; 2000 Apr; 88(8):1909-15. PubMed ID: 10760769
[TBL] [Abstract][Full Text] [Related]
20. Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience.
Scheuba C; Kaserer K; Bieglmayer C; Asari R; Riss P; Drosten R; Niederle B
Surgery; 2007 Dec; 142(6):1003-10; discussion 1010.e1-3. PubMed ID: 18063088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]